H. Lundbeck, Lundbeck and Mochida enter into agreement on the development and sale of Cipralex® in Japan

H. Lundbeck A/S and Mochida Pharmaceutical Co., Ltd have signed a semi-exclusive licence agreement on the development, registration, sale and marketing of Cipralex® (escitalopram) on the Japanese market.